Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000898513 | SCV001042723 | benign | not provided | 2025-01-16 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001002635 | SCV001160618 | uncertain significance | not specified | 2019-06-19 | criteria provided, single submitter | clinical testing | The SAG c.511A>G; p.Lys171Glu variant (rs552862207), to our knowledge, is not reported in the medical literature or gene-specific databases. The variant is found in the South Asian population with an allele frequency of 0.95% (291/30600 alleles including 2 homozygotes) in the Genome Aggregation Database. The amino acid at this position is weakly conserved and computational analyses (SIFT: Damaging, PolyPhen-2: Benign) predict conflicting effects of this variant on protein structure/function. Due to limited information, the clinical significance of the variant is uncertain at this time. |